Marijuana in Pregnancy. Kimberly Butt MD, FRCSC, MFM Fredericton, NB ASOG September 15,2017
|
|
- Johnathan May
- 5 years ago
- Views:
Transcription
1 Marijuana in Pregnancy Kimberly Butt MD, FRCSC, MFM Fredericton, NB ASOG September 15,2017
2 Outline Background Biologic effects Legislation Concerns for pregnancy Concerns for breast feeding Summary
3 Disclosure I have no potential conflict of interest to disclose I am not an expert on marijuana
4 Cannabis vs. Marijuana Used interchangeably Cannabis often used/preferred by physicians and researchers Latin root Marijuana comes from Mexican/Spanish used a lot during the last century of prohibition THC active psychogenic metabolite, delta-9- tetrahydrocannibinol
5 Medical vs. Recreational if used to treat an underlying medical issue it is considered medical application lifestyle enhancement is considered recreational
6 Prevalence 10.6% Canadians 15 and older report pastyear use in 2013 (CTADS) 22.4% age 15-19; 26.2% aged % who use Cannabis in the last 3 months do so daily (Health Canada 2013) Conflicting information on the health risk associated with marijuana and emerging evidence supporting the use for specific medical purposes
7 Cannabis Most commonly used illicit drug in Canada Psychoactive drug from the Cannabis plant Main psychoactive ingredient is THCtetrahdrocannabinol 65 other cannaboids Can be smoked, vaporized, eaten in food and taken as an extract.
8 Pharmacology Highly lipid soluble Persists in body for a long period of time. THC can be found in the body for weeks and or longer depending on quantity particularly the lipid membrane of neurons Effects CB 1 (central CNS)and CB 2 (peripheral)receptors CB 1 receptor in the brain increases dopamine and the psychotropic effects (mood and cognition)
9 Testing Maternal urine, serum: 2-3 days in occasional users/ several weeks, chronic users Maternal hair: several weeks Meconium: positive result indicates second and third trimester exposure Neonatal hair: positive result indicates third trimester exposure
10 Effects Effects: high / stoned feeling euphoria, change in perception, increased appetite Side Effects: decreased short term memory, dry mouth, impaired motor skills, red eyes, and paranoia and anxiety. addiction, decreased mental ability (when started as a teen), behavioral problems.
11 Legislation Marijuana for Medicinal Purposes Regulation (MMPRs) Introduced in June 2013 by Health Canada Healthcare practitioners are responsible for providing a medical document (prescription) to authorize patient access to marijuana from a licensed supplier. Three forms of marijuana-based pharmaceutical drugs approved by Health Canada. Dronabinol(pill), nabilone(pill), and nabiximols(spray)
12 Licensed Producers/ Dispensary The only legal way to buy marijuana in Canada is through a licensed producer (LP). There are 38 and counting licensed by Health Canada to grow or sell to patients Once you have a valid prescription you register with an LP, place an order online or by phone and wait for delivery to your home. Dispensaries are not technically legal and operate with varying intentions
13 Physician Guidelines College of Family Physicians of Canada released guidelines in Agreement that: Evidence lacking on indications, dosage, interactions, risk and benefits First exhaust conventional treatments CFPC- consider only for neuropathic pain that has not responded to other treatments
14 Clinical Trials Information for Health Care Professionals: Cannabis and the Cannabinoids [Health Canada 2013] 138 pages. Reviews all the clinical trials at the time.
15 Potential Indications Palliative care Nausea/vomiting Wasting syndrome Loss of appetite with cancer/anorexia/aids MS, ALS, spinal cord injury Epilepsy Acute/chronic pain Arthritis Movement disorders Glaucoma Asthma Hypertension Psychiatric disorders Alzheimer/dementia Inflammation GI disturbance Anti-neoplastic properties
16 Legislation: Non-Therapeutic Use Proposed Cannabis Act Target date for implementation is July 2018 Hope to create a strict legal framework for controlling the production, distribution, sale and possession across Canada No person could sell or provide cannabis to those under age of 18. Over age 18 or older you could possess, share, purchase, grow make cannabis/products
17 Legislation Federal Government: set strict requirements for producers set industry-wide standards Provinces/ Territories: Oversee distribution and sales Could increase the minimum age Lower the possession limit Create additional rules for growing Restrict where it is consumed publicly
18 Sources of Information Provincial colleges New Brunswick Medical Society has developed It s Your Choice Campaign Legal Not Safe : Recreational Marijuana Doctors Nova Scotia has a statement on Legalizing Marijuana NL and PEI do not comment on the websites
19
20 Clearing the Smoke on Cannabis Maternal Cannabis Use during Pregnancy-An Update Prevalence 11% of women childbearing age use cannabis 5% admit illicit drug use in pregnancy (cannabis not specified) up to 25-30% in inner city populations Endocannabinoid system plays a significant role in many developmental processes in the embryonic brain (proliferation, differentiation, neuronal development, neurotransmitter and behavioral disturbances). Significant potential to influence postnatal development and behavior Porath-Waller, Director CCSA
21 Pregnancy Outcomes After controlling for tobacco, alcohol and other drugs and demographic characteristics: Not associated with preterm birth Not associated with miscarriage Not associated with physical abnormalities In the Ottawa Prenatal Prospective Study Mothers who use THC 6 or more x / week have approx 1 week reduction in pregnancy gestational age at delivery Porath-Waller, Director CCSA
22 Pregnancy Outcomes Report of increased hyper-telorism, severe epicanthus 5x increase in features of FAS Meta-analysis of over 10 studies found only weak evidence of association with reduction in birth weight and low birth weight. Porath-Waller, Director CCSA
23 Neurocognitive Functioning Maternal use has subtle effects on children s neurocognitive functioning. General intelligence does not appear to affected. Porath-Waller, Director CCSA
24 Neurocognitive Functioning 18 month Increased aggressive behavior Attention deficits (females) 3-6 years Verbal and perceptual skills Verbal, visual and quantitative reasoning Short term memory Hyperactivity Attention deficits Impulsivity Impaired vigilance 9-10 years Deficits in: abstract and visual reasoning Executive functioning Reading Spelling Hyperactivity Attention deficits Impulsivity Depressive and anxious symptoms
25 Neurocognitive Functioning years Deficits in: Visual-cognitive functioning Academic achievement Information processing speed Visual motor coordination Delinquency years Deficits in: Executive function Response inhibition Visuospatial working memory Smoking Substance use Early initiation of substance use
26 Behavioral Effects Less clear before the age of 6 yrs. After 6 years: More hyperactive Inattentive Impulsivity At 10 years: Increased hyperactivity Inattention Impulsivity Increased delinquency Externalizing problems Age 14: More frequent initiation and daily cigarette smoking, cannabis use
27 Other Mental health More depressive and anxious symptoms at age 10. An area that requires further research.
28 Marijuana in Pregnancy SOGC Position Statement (May 2017) Concern that it is most commonly used illicit drug in pregnancy Legalizing cannabis will result in increased use Evidenced based data shows: Adversely affect growth Adversely affect development Long-term learning and behavioral consequences Additional concern about maternal and fetal effects of smoking exposure Adverse effects can be life long
29 SOGC Women who are pregnant or considering pregnancy abstain from cannabis use during pregnancy HCP discuss potential adverse health effects and recommend to discontinue to those who are/or contemplating pregnancy Cannabis for medicinal purposes strongly discouraged in favor of other therapies Abstain during lactation and breastfeeding Further research Public education be funded
30 ACOG Review Marijuana use in pregnancy and lactation: a review of the evidence Summary: Growth - literature inconsistent Stillbirth - may be increased but needs further study because of possible confounding by tobacco use. Preterm birth - literature inconsistent (potential confounders). Congenital anomalies - literature does not support an association Neurodevelopment concerning pattern of altered neurodevelopment with early, heavy maternal use of marijuana Metz et al December 2015
31 ACOG Review Marijuana use in pregnancy and lactation: a review of the evidence Breast feeding: Amount the reaches infant 0.8% of maternal exposure In studies it is difficult to ascertain the difference in prenatal and lactation exposure as 84% of mothers did both. AAP statement says breast-feeding is contraindicated with illicit drugs. More information is needed. Metz et al December 2015
32 ACOG-Committee Opinion 2015 Recommendations: All women before or during pregnancy should be asked about use of tobacco, alcohol, marijuana and other drugs used for non-medical purposes Because of concerns regarding adverse neurodevelopment, adverse fetal effects of smoking, women who are pregnancy or contemplating pregnancy should be encouraged to discontinue use.
33 ACOG Ob-Gyn should be discouraged from prescribing or suggesting the use of marijuana for medical purposes during preconception, pregnancy and lactation. Alternative therapies with better pregnancyspecific safety data Marijuana use is discouraged during lactation and breastfeeding as there is insufficient data.
34 ABM Clinical Protocol #21 (2015) Carefully weigh the risks of not breastfeeding with the risks of continuing to breast feed wile using marijuana, while also considering the wide range of exposure. THC (the main compound in marijuana) is present in breast milk up to 8 x the level in maternal plasma Metabolites are found in infant feces indicating it is absorbed and metabolized by the infant.
35 ABM Clinical Protocol #21 (2015) It is rapidly distributed to the brain and adipose tissue It is stored in fat tissue for weeks to months It has a long half life (25-57 hours) Stays positive in urine for 2-3 weeks Evidence of THC exposure by breast feeding alone is sparse No data evaluating infant outcomes beyond 1 year. Potency has increased from 3% in 1980s to 12% in Concerns about infant sedation and maternal inability to care for infant under the influence remains a theoretical concern.
36 ABM Clinical Protocol #21 (2015) Endocannabinoid system plays a crucial role in the ontogeny of the CNS. THC exposure during critical periods of brain development can induce subtle long-lasting neurofunctional alterations (cognitive functions and emotional behaviors) Second hand smoke increases 2x risk for SIDS.
37 ABM Clinical Protocol #21 (2015) Summary A. Occasional/rare use: avoid or reduce use while breastfeeding. Advise of potential for adverse long term neurobehavioral effects and avoid direct exposure to THC and smoke. B. Advise women with a positive urine screen to discontinue exposure while breastfeeding C. Medicinal use. Review potential risks and benefits D. Moderate/chronic use: Abstaining from any marijuana use is warranted. Urge caution with any marijuana use.
38 Summary Information is limited, more research needed Neurobehavioral outcomes are concerning These effects may not be evident until the child is older Effects of smoking concerning Legalizing it will make use more prevalent in pregnancy Talk to your patients about it
39 References Porath-Walker, A. Clearing the Smoke on Cannabis. Maternal Cannabis Use during pregnancy-an update. Canadian Centrre on Substance Abuse, Metz, T. Marijuana use in pregnancy and lactation: a review of the evidence. AJOG December NBMS. Legal Not Safe: Recreational Marijuana. ( Marijuana for Medical Purposes. CCSA. Policy Brief 2015 Marijuana. CCSA. July 2017.
40 References Wong S,et al. Substance Use in Pregnancy. SOGC CPG. April Marijuana Use During Pregnancy and Lactation. ACOG. Committee Opinion, July Reece-Stremtan A, et al. ABM Clinical Protocol #21: Guidelines for Breastfeeding and Substance Use or Substance Use Disorder, revised SOGC Position Statement: Marijuana Use during Pregnancy. May 9,201. What You Need to Know About Marijuana Use and Pregnancy. CDC 2017.
41 References Legalizing and Strictly Regulating Cannabis: The Facts. GOC Information for Health Care Professionals: Cannabis and the Cannabinoids. Health Canada pages.
What To Expect. Maternal Cannabis Use during Pregnancy and the Impacts on Offspring
www.ccsa.ca www.cclt.ca What To Expect Maternal Cannabis Use during Pregnancy and the Impacts on Offspring Presentation for: 2016 Best Start Conference Amy Porath-Waller, PhD Katie Fleming, MA February
More informationMarijuana in the Obstetric Population
Marijuana in the Obstetric Population Brittany MacGregor PGY 1 on behalf of Sophia Lenson PGY 3, Queens OB/Gyn Objectives 1. Review the status of legalization of cannabis products in Canada and the potential
More informationMarijuana in Pregnancy
Idaho Perinatal Project 2019 Winter Conference Marijuana in Pregnancy What are we telling our patients? Stacy T. Seyb, MD Kristy Schmidt, MN, RN, NEA-BC Special Thanks to Tori Metz, MD University of Utah
More informationMARIJUANA USE AMONG PREGNANT AND POSTPARTUM WOMEN
MARIJUANA USE AMONG PREGNANT AND POSTPARTUM WOMEN Symposium on Marijuana Research in Washington May 18, 2018 THERESE GRANT, PH.D. PROFESSOR, DEPARTMENT OF PSYCHIATRY & BEHAVIORAL SCIENCES UNIVERSITY OF
More informationRecent trends in medical cannabis use in Canada
Recent trends in medical cannabis use in Canada Paul Grootendorst Faculty of Pharmacy, University of Toronto Department of Economics, McMaster University Cannabis therapeutic effects Cannabis has been
More informationINITIAL PATIENT INTAKE FORM
INITIAL PATIENT INTAKE FORM Name: Last Name First Name Date of Birth: MM / DD / YYYY Gender: Male Female Address: Town: State: Zip Code: Preferred method of contact. For internal promotional use only.
More informationMarijuana Use During Pregnancy and Breastfeeding Findings Summary
The Colorado Department of Public Health and Environment (CDPHE) was assigned the responsibility to appoint a panel of health care professionals with expertise in cannabinoid physiology to monitor the
More informationISSUE: BACKGROUND: CanFASD Issue Paper: Cannabis Use During Pregnancy. March 2018
CanFASD Issue Paper: Cannabis Use During Pregnancy Kelly D. Harding, PhD and Nancy Poole, PhD Canada Fetal Alcohol Spectrum Disorder Research Network ISSUE: In 2018, the Canadian government plans to introduce
More informationPOLICY NUMBER: POL 153
Chapter: CLAIMS Subject: MEDICAL CANNABIS Effective Date: October 25, 2018 Last Update: October 25, 2018 PURPOSE STATEMENT The purpose of this policy is to explain how the Workers Compensation Board determines
More informationAcknowledgements: What it is What it s not. Cannabis Evidence Series. Evidence-informed decision-making
Cannabis Evidence Series What it is What it s not Acknowledgements: The evidence presented is from the Cannabis evidence series authored by the HTA unit at the University of Calgary and from Rapid response
More informationMedicinal Cannabis. Patient Log Book. Record your cannabis use and find the right dose
Medicinal Cannabis Patient Log Book Record your cannabis use and find the right dose 1 Introduction A federal system is in place for medicinal cannabis that is distinct from recreational sales. To get
More information4/15/2019. US States with Marijuana Laws in Have ACOG and SMFM taken notice? THE EFFECTS OF MARIJUANA USE ON PREGNANCY AND LACTATION
THE EFFECTS OF MARIJUANA USE ON PREGNANCY AND LACTATION Susan R Davidson, MD Maternal Fetal Medicine Department of Ob/Gyn St. Mary s Hospital Madison, WI SSM Health I HAVE NO FINANCIAL DISCLOSURES TO REPORT
More informationPATIENT QUESTIONNAIRE
PATIENT QUESTIONNAIRE Personal Information Date Name Date of Birth Age Height Weight Gender: Male / Female Address City State / Zip Home Phone Cell phone Work phone E-mail address Do you currently have
More informationMARIJUANA IN PREGNANCY: Now that it is legal
MARIJUANA IN PREGNANCY: Now that it is legal June 7, 2018 42 nd Annual Antepartum and Intrapartum Management No financial disclosures DISCLOSURES Lena H. Kim, MD MFM, Sutter Health, California Pacific
More informationCANNABIS LEGALIZATION: SUPPORT MATERIAL FOR MANITOBA PHYSICIANS
CANNABIS LEGALIZATION: SUPPORT MATERIAL FOR MANITOBA PHYSICIANS 1. GENERAL INFORMATION Cannabis 101 What is cannabis? Cannabis is a product derived from the Cannabis sativa plant. Cannabis contains hundreds
More informationMedical Cannabis MATT WEBSTER DO, MS
Medical Cannabis MATT WEBSTER DO, MS Cannabis Sativa One of the oldest used drugs and medicinal remedies Most commonly abused illicit drug in the US There has been increasing access for medicinal MJ use
More informationUse of Cannabinoids in Medical Practice
Use of Cannabinoids in Medical Practice Annual Scientific Assembly Family Medicine Review 2016 Murray Opdahl BSPE, MD, CCFP Objectives Briefly present: An overview of available cannabinoids Concerns voiced
More information4/15/2019. Dickson, et al Obstet Gynecol Marijuana Use and Pregnancy. Conner, et al AJOG Conner, et al Obstet and Gynecol 2016
Dickson, et al Obstet Gynecol 2018 69% of dispensaries (277/400) recommended cannabis products for morning sickness Of those who recommended cannabis for morning sickness 65% based their recommendation
More informationPATIENT INTAKE FORM. Name: Address: Town: State: Zip Code: MMJ Card #: Exp. Date: Drivers License #: Exp. Date: Home Phone: Cell:
PATIENT INTAKE FORM Name: Last Name First Name Date of Birth: / / Gender: Male Female Address: Town: State: Zip Code: MMJ Card #: Exp. Date: Drivers License #: Exp. Date: Home Phone: Cell: Email: Primary
More informationAn Overview of the Government of Canada s Approach to Legalize, Regulate and Restrict Access to Cannabis
An Overview of the Government of Canada s Approach to Legalize, Regulate and Restrict Access to Cannabis I m here today to provide 1 2 3 Context for the Government of Canada s plan to legalize, regulate
More informationTorri Metz, MD Maternal-Fetal Medicine December 15, 2017
Torri Metz, MD Maternal-Fetal Medicine December 15, 2017 I have no relevant financial relationships to disclose or conflicts of interest to resolve. Describe public health impact of expanding marijuana
More informationAn Overview of the Government of Canada s Approach to Legalize, Regulate and Restrict Access to Cannabis. February 2018
An Overview of the Government of Canada s Approach to Legalize, Regulate and Restrict Access to Cannabis February 2018 I m here today to provide 1 2 3 Context for the Government of Canada s plan to legalize,
More informationThese documents were created to support the work of the Coalition of Colorado Campus Alcohol and Drug Educators. We welcome prevention teams at
These documents were created to support the work of the Coalition of Colorado Campus Alcohol and Drug Educators. We welcome prevention teams at institutions of higher education to utilize these documents
More informationCannabis and What we Know. Bonnie Schnittker RN PHN Public Health Nurse October 20, 2017
Cannabis and What we Know Bonnie Schnittker RN PHN Public Health Nurse October 20, 2017 We All Have a Role to Play! Objectives What is Cannabis? What do we know about the health effects? Legalization:
More informationMedical Cannabis. Danial Schecter, MD, CCFP. Vocational Rehabilitation Association November 7th, Executive Director Cannabinoid Medical Clinic
Medical Cannabis Danial Schecter, MD, CCFP Executive Director Cannabinoid Medical Clinic Vocational Rehabilitation Association November 7th, 2014 Conflict of Interest This program has not received financial
More informationMedical Marijuana Consent Form
Medical Marijuana Consent Form A qualified physician may not delegate the responsibility of obtaining written informed consent to another person. The qualified patient or the patient s parent or legal
More informationCANADIAN CANNABIS CRAZE (AND CONUNDRUM) Dr. Melissa Snider-Adler Chief Medical Review Officer DriverCheck Inc. Addiction Medicine Physician
CANADIAN CANNABIS CRAZE (AND CONUNDRUM) Dr. Melissa Snider-Adler Chief Medical Review Officer DriverCheck Inc. Addiction Medicine Physician AGENDA THC IMPAIRMENT A deep dive into THC vs. CBD Signs and
More informationCounseling Guidelines: Breastfeeding and Maternal Alcohol, Tobacco and Other Drug Use
Counseling Guidelines: Breastfeeding and Maternal Alcohol, Tobacco and Other Drug Use May 2008 These guidelines were developed by the Sonoma County Breastfeeding Coalition and the Sonoma County Perinatal
More informationNeonatal Abstinence Syndrome Questions & Answers Webinar #1 (February 9, 2012) Webinar #2 (March 30, 3012)
Neonatal bstinence Syndrome Questions & nswers Webinar #1 (February 9, 2012) Webinar #2 (March 30, 3012) For more information and to download a copy of the NS Clinical Practice Guidelines, please visit
More informationMarijuana During Pregnancy: An Overview
Marijuana During Pregnancy: An Overview Marijuana: Epidemiology Marijuana is the most commonly used illicit drug and, after alcohol and tobacco, the most commonly used drug during pregnancy (1) 48-60%
More informationMARIJUANA & THE EFFECTS ON THE BRAIN
MARIJUANA & THE EFFECTS ON THE BRAIN Sheryl Ryan, MD Professor of Pediatrics Chief, Division of Adolescent Medicine, Penn State Health Hershey Medical Center DISCLOSURES I have no relevant financial relationships
More informationMedical Marijuana and the Workplace: Human Rights Considerations for ONA Members
Medical Marijuana and the Workplace: Human Rights Considerations for ONA Members Presented by: Pauline Lefebvre-Hinton, HRE/RTW Specialist Alyssa Lane, Legal Counsel October 2, 2018 Agenda 1. What is cannabis?
More informationMarijuana and Adolescents: Truth and Consequences. Disclosure Statement OBJECTIVES. Secondary Objectives. State of Marijuana in US
Marijuana and Adolescents: Truth and Consequences Clinical Advances in Pediatrics Symposium Children s Mercy Park September 28, 2017 Disclosure Statement I have no actual or potential conflict of interest
More informationObjectives. 1. Review controversy 2. Pathophysiology 3. Indications for Use 4. Adverse Effects 5. How Patients Access
Medical Marijuana Deb Evans, RN, MScN, CON(C), CHPCN(C) Clinical Nurse Specialist Pain and Symptom Management Team Juravinski Cancer Centre May 29, 2014 Objectives 1. Review controversy 2. Pathophysiology
More informationEffects of Prenatal Illicit Drug. Use on Infant and Child
Effects of Prenatal Illicit Drug Use on Infant and Child Development Andrew Hsi, MD, MPH Larry Leeman, MD, MPH Family Medicine MCH Grand Rounds 6 July 2011 Objectives for Presentation At the end of this
More informationImportant Information
Important Information Please work through the following pages with your patient or the patient s chart as necessary. Fax completed documents to 1 888 629-4722. Keep the original in your chart / file. Fee:
More informationUnderstanding Prenatal Drug Exposure
Understanding Prenatal Drug Exposure Prenatal Drug Exposure A mother s drug use hurts her unborn baby. Slide 2 Drug Categories Part 1 Prescription drugs: Prescribed by a doctor and used under a health
More informationAre We All Going to Pot?: Legal Issues Arising from Cannabis-Industry Growth The Canadian Perspective
Are We All Going to Pot?: Legal Issues Arising from Cannabis-Industry Growth The Canadian Perspective John A. Myers and Colin B. Findlay SCG Legal Annual General Meeting September 16, 2016 Boston Licensed
More informationCANNABIS AND CANADA S CHILDREN AND YOUTH CPS Podcast
CANNABIS AND CANADA S CHILDREN AND YOUTH CPS Podcast Developed by KEON MA and Dr. CHRISTINA GRANT for PedsCases.com July 6, 2018 INTRODUCTION: Keon: On June 21, 2018, Bill C-45, also known as the Cannabis
More informationCannabis for Medical Purposes
College of Physicians and Surgeons of British Columbia Cannabis for Medical Purposes Preamble This document is a standard of the Board of the College of Physicians and Surgeons of British Columbia. College
More informationLessons Learned. Marijuana Education & Prevention in Colorado
Lessons Learned Marijuana Education & Prevention in Colorado Jessica Neuwirth Retail Marijuana Education & Youth Prevention Coordinator, Prevention Services Division CDPHE ON Enact the will of the people
More informationPATIENT QUESTIONNAIRE
PATIENT QUESTIONNAIRE Personal Information please include all requested information Date Name Date of Birth* Age Address* City State Zip* Home Phone Cell phone* E-mail address* SSN*: - - *required information
More informationPuget Sound Educational Service District
Puget Sound Educational Service District Before we begin..thank you! Agenda-Introductions and Reflection Marijuana Prevention Closing and Reflection Why Are We Here? Let s Hear From You. Name. School/Work/Community
More informationFrequently Asked Questions
Frequently Asked Questions Legal 1. Can I use cannabis? You can legally use cannabis if you are 21 or older. You can also use cannabis if you are 18 or older and have a current qualifying physician s recommendation
More informationCAPC/CPNP Coalition Face to Face Meeting October 18, 2018
CAPC/CPNP Coalition Face to Face Meeting October 18, 2018 Topics What is cannabis and how is it used? What does the evidence say about health effects? What about effects during pregnancy and breastfeeding?
More informationConsumer Information Cannabis (Marihuana, marijuana)
Consumer Information Cannabis (Marihuana, marijuana) The courts in Canada have ruled that the federal government must provide reasonable access to a legal source of marijuana for medical purposes. The
More informationJanuary 19, Cannabis Legalization and Regulation Secretariat Address locator 0602E Health Canada Ottawa, Ontario K1A 0K9
January 19, 2018 Cannabis Legalization and Regulation Secretariat Address locator 0602E Health Canada Ottawa, Ontario K1A 0K9 By email: cannabis@canada.ca RE: Proposed Approach to the Regulation of Cannabis
More information420 ADVISORY MANAGEMENT
THE CANNABIS ACT: WHAT DOES IT MEAN FOR CANADIANS? 420 CLINIC, LTD. OBJECTIVES At the end of the session, you will be able to: 1) Understand the ramifications of recreational cannabis legalization 2) Understand
More informationCannabis in the Community
Department of Pediatrics Cannabis in the Community The Unintended Consequences of Increased Marijuana Availability on the Pediatric Population Karen Buchi, MD Professor of Pediatrics Chair, University
More informationTorkin Manes LegalPoint
LegalPoint JULY 2017 Marijuana and the Canadian Workplace The possession, use and sale of marijuana in Canada presently remains unlawful under the Controlled Drugs and Substances Act, but its use for medical
More informationDr. Meldon Kahan. Women s College Hospital. with PIA LAW
with PIA LAW and Toronto ABI Network Dr. Meldon Kahan Women s College Hospital Dr. Meldon Kahan is an Associate Professor in the Department of Family Medicine at University of Toronto, and Medical Director
More informationBlazing the Trail in Colorado Marijuana and Public Health
Blazing the Trail in Colorado Marijuana and Public Health Tista Ghosh, MD, MPH November 2012 1 Public Health Responsibilities 1. Monitor patterns of use 2. Monitor health outcomes 3. Create a scientific
More informationYukon s Proposed Framework for. Legalized Cannabis 30 GRAMS MINIMUM AGE
Yukon s Proposed Framework for Legalized Cannabis 30 GRAMS x4 MINIMUM AGE Overview The Government of Yukon has begun developing a new act to regulate cannabis in response to federal legislation planned
More informationOutcome. Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana. Connie J. Cerilli, APRN, FNP-C
Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana Connie J. Cerilli, APRN, FNP-C Outcome Participants will be able to list 3 approved medical conditions Participants will
More informationEducating Ohio Providers On The Basics Related To Recommending Medical Marijuana. Connie J. Cerilli, APRN, FNP-C
Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana Connie J. Cerilli, APRN, FNP-C Outcome Participants will be able to list 3 approved medical conditions Participants will
More informationMarijuana and the Workplace : Changing Times
Marijuana and the Workplace : Changing Times By: Stéphane Thiffeault 2018 AMCTO Conference Blue Mountain Resort June 12, 2018 Presentation Outline Current Status of Cannabis Some Facts and Statistics Summer
More informationPLENARY PANEL THE INTERSECTION OF MENTAL HEALTH AND MARIJUANA LEGALIZATION
STANFORD ADOLESCENT MENTAL WELLNESS CONFERENCE: OVERCOMING CULTURAL BARRIERS TO ACCESS PLENARY PANEL THE INTERSECTION OF MENTAL HEALTH AND MARIJUANA LEGALIZATION Time: Friday, April 27, 3:15-4:15p Paula
More informationAGENDA. 9:00 Sign-in and introductions 9:15 Marijuana 10:30 Break 10:45 Opioid Prevention 11:30 Discussion & Wrap-Up
AGENDA 9:00 Sign-in and introductions 9:15 Marijuana 10:30 Break 10:45 Opioid Prevention 11:30 Discussion & Wrap-Up Marijuana: Preventing Youth Use Juliet D Alessandro, Healthy Communities Specialist Today
More informationPATIENT QUESTIONNAIRE
PATIENT QUESTIONNAIRE Personal Information Date Name Date of Birth Age Height Weight Address City State Zip Home Phone Cell phone Work phone E-mail address SSN: - - Medical History - you must enter information
More informationPerinatal Substance Use: Evidence for Current Practice. Karen Clemmer, MCAH Coordinator, Sonoma County
Perinatal Substance Use: Evidence for Current Practice Karen Clemmer, MCAH Coordinator, Sonoma County The impact of perinatal marijuana use on pregnancy outcomes & lactation Learning Objectives Influence
More informationMedical Marijuana Update Chris Belletieri, DO
Dr. Belletieri has provided no disclosures. Graduated PCOM in 1996 In private practice since 1999 Board Certified in FP since 1999 Program Director of FP residency at Lower Bucks Hospital in Bristol, PA
More informationCannabis Legalization and Regulation
Cannabis Legalization and Regulation Presentation to alpha Ontario Public Health Unit Collaboration on Cannabis February 24, 2017 Elena Hasheminejad and Allison Imrie 1 Overview The Ontario Public Health
More informationJames Donaldson CEO and Executive Director
Welcome! James Donaldson CEO and Executive Director Dr. Natasha Ryz Chief Science Officer, Zenabis Cannabis 101 Introduction to Cannabis Plant Cannabis is a genus of flowering plants within the family
More informationJuly 15 TH, ANDREW MEDVEDOVSKY, M.D. Board Certified Neurologist & Pain Medicine Specialist Director New Jersey Alternative Medicine
MEDICAL CANNABIS FOR NEUROLOGICAL DISEASES July 15 TH, 2017 ANDREW MEDVEDOVSKY, M.D. Board Certified Neurologist & Pain Medicine Specialist Director New Jersey Alternative Medicine GOALS AND OBJECTIVES
More informationSubstance Use in Pregnancy and Breastfeeding Lisa Graves MD CCFP FCFP
+ Substance Use in Pregnancy and Breastfeeding Lisa Graves MD CCFP FCFP Physician CATC clinics Sudbury and Parry Sound ON Professor Family and Community Medicine Western Michigan University Homer Stryker
More informationLife s brighter under the sun MEDICAL CANNABIS AND GROUP BENEFITS PLAN COVERAGE
Life s brighter under the sun MEDICAL CANNABIS AND GROUP BENEFITS PLAN COVERAGE With the legalization of recreational cannabis upon us in Canada, our conversation about cannabis use is changing. It s not
More informationImportant Information
Important Information Please work through the following pages with your patient or the patient s chart as necessary. Fax completed documents to 1 888 629-4722. Keep the original in your chart / file. Fee:
More informationFaculty/Presenter Disclosure
Faculty/Presenter Disclosure Faculty: Philippe Lucas Relationships with commercial interests: Philippe Lucas is a Research Affilliate with the Centre for Addictions Research of BC, as well as VP, Patient
More informationPrenatal Cocaine Exposure: Scientific Considerations and Policy Implications
SUMMARY Prenatal exposure to drugs, including cocaine, is a significant and preventable cause of developmental disability. Almost two decades after the nation first heard stories of crack babies, new research
More informationLegalization of Cannabis: Let s Protect Future Generations POSITION PAPER
Legalization of Cannabis: Let s Protect Future Generations June 3rd 2017 Contents FOREWORD 4 1. THE POLITICAL CONTEXT 5 2. THE CLINICAL CONTEXT 7 The development of the human brain 7 The effects of consuming
More informationINITIAL PATIENT INTAKE FORM
INITIAL PATIENT INTAKE FORM Name: (Please, print legibly) Registry ID: Date of Birth: MM / DD / YYYY Gender: Male Female Address: Town: State: Zip Code: Preferred method of contact. For internal promotional
More informationHealth Care Professionals Forum. May 19, 2016
Health Care Professionals Forum May 19, 2016 Statistics Update Licensed Producers There are currently 31 licenses for the production of marijuana for medical purposes There are approximately 400 applications
More informationLegalization of Cannabis: The Way Forward
Percent 2018/05/03 Legalization of Cannabis: The Way Forward W. O. McCormick Academic Day Hon. A. Anne McLellan, PC, OC, AOE Friday, April 27 2018 Current Context 40 Past year cannabis use, by age group,
More informationMAT IN PREGNANCY KAYLA LIFE STAGE 1: ADOLESCENCE LIFE STAGE 2: EARLY ADULTHOOD. family History of addiction. addiction to oral opioids
MAT IN PREGNANCY R. COREY WALLER MD, MS PRINCIPAL, HEALTH MANAGEMENT ASSOCIATES FACULTY, INSTITUTE FOR HEALTHCARE INNOVATION (IHI) CHAIR, LEGISLATIVE ADVOCACY COMMITTEE, ASAM KAYLA LIFE STAGE 1: ADOLESCENCE
More informationMarijuana and CDPHE. Tista Ghosh, MD, MPH Deputy Chief Medical Officer
Marijuana and CDPHE Tista Ghosh, MD, MPH Deputy Chief Medical Officer History of Medical Marijuana in Colorado Amendment 20 - November 2000 July 2001 Registry established Ogden Memorandum 10/2009 Commercial
More informationResearch: Medical Cannabis
Research: Medical Cannabis Background The hemp plant Cannabis sativa (cannabis) is commonly known as marijuana and can be used as a therapy to alleviate symptoms such as pain and fatigue caused by chronic
More informationBlazing the Trail in Colorado Marijuana and Public Health. Tista Ghosh, MD, MPH
Blazing the Trail in Colorado Marijuana and Public Health Tista Ghosh, MD, MPH History of Medical Marijuana in Colorado Amendment 20 - November 2000 July 2001 Registry established Ogden Memorandum 2009
More informationMedicinal cannabis. What is medicinal cannabis? What are cannabinoids? The endocannabinoid system
Medicinal cannabis What is medicinal cannabis? Broadly speaking, medicinal cannabis is cannabis prescribed to relieve the symptoms of a medical condition, such as epilepsy. It is important to make the
More informationUnderstanding the New Access to Cannabis for Medical Purposes Regulations
Understanding the New Access to Cannabis for Medical Purposes Regulations Health Canada August 2016 Table of Contents 1. Introduction 2. Health Canada's role 3. What it means for health care practitioners
More informationSurveillance report Published: 8 June 2017 nice.org.uk. NICE All rights reserved.
Surveillance report 2017 Antenatal and postnatal mental health: clinical management and service guidance (2014) NICE guideline CG192 Surveillance report Published: 8 June 2017 nice.org.uk NICE 2017. All
More informationIn order to do this we want a consistent approach from Sheffield agencies to maximise the impact of this work.
The Citywide response to Spice use in Sheffield Spice use needs a co-ordinated response. Our vision is that all workers in contact with Spice users will have the opportunity to respond to Spice use in
More informationCannabis in the Workplace: Lessons Learned. Sponsored by:
Cannabis in the Workplace: Lessons Learned Sponsored by: Andrew Freedman Dr. Melissa Snider-Adler Neil Tidsbury Holly Hale Session Overview: 20-Minute address 30-Minute Q&A Andrew Freedman Co-Founder &
More informationMarijuana in Pregnancy and Lactation: Weeding Out the Myths
Marijuana in Pregnancy and Lactation: Weeding Out the Myths Laura M. Borgelt, PharmD, FCCP, BCPS Professor University of Colorado Anschutz Medical Campus Colorado Perinatal Care Council July 2014 Disclosures
More informationPrenatal and Post Partum Depression is Not Just a Mood. This is Serious Stuff.
Prenatal and Post Partum Depression is Not Just a Mood. This is Serious Stuff. Deborah McMahan, MD Health Commissioner Prenatal and Infant Care Network November 28, 2016 Agenda Prevalence of mental illness
More informationOMA Submission on Health Canada s Proposed Regulations for Additional Cannabis Products. February 2019
OMA Submission on Health Canada s Proposed Regulations for Additional Cannabis Products February 2019 OMA Submission on Health Canada s Proposed Regulations for Additional Cannabis Products The Ontario
More informationMedical Cannabis: A Patient Primer
Medical Cannabis: A Patient Primer This primer is meant for documented patients who are using medicinal cannabis or considering using it in the future. The information provided about this medication in
More informationMaternal Substance Abuse: Challenges & Opportunities for Perinatal Nurses Catherine H. Ivory, PhD, RNC-OB October, 2015
Maternal Substance Abuse: Challenges & Opportunities for Perinatal Nurses Catherine H. Ivory, PhD, RNC-OB October, 2015 Objectives Discuss the current scope of maternal substance use and abuse List examples
More informationHistory Of Medical Cannabis
History Of Medical Cannabis Historical and archaeological evidence of widespread use in ancient times as medicine, food, textiles & for sacraments, rituals Possibly first domesticated crop Introduction
More informationHome Phone Cell Phone
Patient Assessment Form For patients seeking ACMPR Access to Cannabis for Medical Purposes General Information First Name D.O.B YEAR MONTH DAY Last Name Gender Male Female Age If female, are you Lic. Producer
More informationIs the most common illicit drug used in the United States. After a period of decline in the last decade, its use has been increasing among young
The Facts Cannabis, commonly known as marijuana and by numerous other names, is a preparation of the cannabis plant intended for use as a psychoactive drug and now as medicine. Marijuana also refers to
More informationReefer Madness version 3.0*
Reefer Madness version 3.0* Presenter Disclosure *Original Reefer Madness: FMF 2014 by R. Dubin, Sharon Cirone and Mel Kahan Update on Health Canada s MMPR and the use of cannabis for medical conditions
More informationExplanatory note for Operational Policy Manual (OPM) # , Cannabis for Medical Purposes
Medical Cannabis Explanatory note for Operational Policy Manual (OPM) #17-01-10, Cannabis for Medical Purposes WSIB Explanatory note for OPM #17-01-10, Cannabis for Medical Purposes January 2019 1 Table
More informationCBD USER GUIDE CUREDNUTRITION.COM CBD INFUSED PRODUCTS MADE FROM COLORADO-GROWN ORGANIC HEMP
CBD USER GUIDE CUREDNUTRITION.COM CBD INFUSED PRODUCTS MADE FROM COLORADO-GROWN ORGANIC HEMP table of contents All about CBD What are Cannabinoids What is CBD? How is CBD different from THC? The Endocannabinoid
More informationOntario Medical Association. Recommendations to the Ministry of the Attorney General on Recreational Cannabis Consultation
Ontario Medical Association Recommendations to the Ministry of the Attorney General on Recreational Cannabis Consultation OMA Recommendations to the Ministry of the Attorney General on Recreational Cannabis
More informationWHO Expert Committee on Drug Dependence Pre-Review: Extracts and tinctures of cannabis. Expert Peer Review 2
WHO Expert Committee on Drug Dependence Pre-Review: Extracts and tinctures of cannabis Expert Peer Review 2 1. Comments based on the review report a. Evidence on dependence and abuse potential Extracts
More informationOutcomes of Infants with Neonatal Abstinence Syndrome
Outcomes of Infants with Neonatal Abstinence Syndrome Caroline O. Chua, MD, FAAP Medical Director, Division of Neonatology Director, Neonatal Follow Up Clinic Nemours Children s Hospital Orlando, Florida
More informationMedical Marijuana. Navigating Medical Marijuana in Workers Compensation
Medical Marijuana Navigating Medical Marijuana in Workers Compensation Agenda Federal and State Laws Public Health Adverse Effects & Concerns Clinical Use Implications for Employers Implications for Workers
More informationFunding for TIPS provided by: The State of Tennessee Portions of this presentation 2002 The American College of Obstetricians and Gynecologists
A training offered by Dr. Beth Bailey, Associate Professor of Family Medicine, East Tennessee State University; and by the Tennessee Intervention for Pregnant Smokers (TIPS) Program Funding for TIPS provided
More informationNew Patient Information Form
New Patient Information Form Patient Identification Prenatal Alcohol & Drug Exposure Clinic FASD CLINIC Patient s OHIP N. Female Male Race Patient s Name Birth Date Age First Middle Last Patient s Address
More informationCannabis use carries significant health risks, especially for people who use it frequently and or/begin to use it at an early age.
Background: The Centre for Addiction and Mental Health (CAMH) released recommendations for the Legalization of Marijuana (with restrictions and regulations) on October 8, 2014. Addiction Services of Thames
More information